nothing
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with good mental state and no communication barriers, second cesarean section, placental implantation or placenta previa; 2. Patients and their families voluntarily sign informed consent forms; 3. No history of allergies to opioid and amide local anesthetics
Exclusion criteria
Exclusion criteria: 1. psychosis, diabetes, accompanied with neurological diseases; 2. Contraindications for spinal anesthesia such as infection and coagulation dysfunction at the puncture site 3. Complete placenta previa and emergency events such as rescue during surgery; 4. Long term use of analgesic drugs; 5. Patients with severe heart, liver, kidney and other functional impairments and a history of bleeding tendency; 6. Patients who withdrew from the study midway or did not complete relevant data follow-up statistics, as well as other situations that are not suitable for this study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Surgical time;Bleeding volume;PCA frequency;Infusion volume; 25/10000 25/1000015Apgar Apgar score at 1 min and 5 min of newborn birth; | — |
Primary
| Measure | Time frame |
|---|---|
| The occurrence of adverse reactions such as nausea and vomiting, chest tightness, dyspnea, chills, skin itching, urinary retention, and back discomfort during the operation;;HR, BP, Sp02 during patient anesthesia;The highest anesthesia level for spinal anesthesia.;Incidence of hypotension in patients;Addition frequency of ephedrine;Changes in VAS scores during intraoperative laparotomy (T2), fetal delivery (T3), and suturing (T4);;VAS scores for pain during rest, exercise, and peak pain at 6 hours (T6) and 12 hours (T7) after surgery;; | — |
Countries
China
Contacts
Ganzhou People's Hospital